Health economics:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
London [u.a.]
Pharmaceutical Press
2010
|
Ausgabe: | 1. ed. |
Schriftenreihe: | Pharmacy business administration series
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis Klappentext |
Beschreibung: | XX, 359 S. graph. Darst. |
ISBN: | 9780853698678 0853698678 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV036092362 | ||
003 | DE-604 | ||
005 | 20130108 | ||
007 | t | ||
008 | 100323s2010 d||| |||| 00||| eng d | ||
020 | |a 9780853698678 |9 978-0-85369-867-8 | ||
020 | |a 0853698678 |9 0-85369-867-8 | ||
035 | |a (OCoLC)624428773 | ||
035 | |a (DE-599)BVBBV036092362 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-1050 |a DE-11 |a DE-355 |a DE-91 | ||
050 | 0 | |a RA410.53 | |
082 | 0 | |a 338.4336210973 |2 22 | |
084 | |a QX 700 |0 (DE-625)142186: |2 rvk | ||
084 | |a XE 1600 |0 (DE-625)152626:12905 |2 rvk | ||
084 | |a MED 722f |2 stub | ||
100 | 1 | |a Braverman, Jordan |e Verfasser |4 aut | |
245 | 1 | 0 | |a Health economics |c Jordan Braverman |
250 | |a 1. ed. | ||
264 | 1 | |a London [u.a.] |b Pharmaceutical Press |c 2010 | |
300 | |a XX, 359 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Pharmacy business administration series | |
650 | 4 | |a Assurance-maladie - États-Unis | |
650 | 4 | |a Soins intégrés de santé - États-Unis | |
650 | 4 | |a Soins médicaux - Coût - États-Unis | |
650 | 4 | |a Économie de la santé - États-Unis | |
650 | 0 | 7 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |2 gnd |9 rswk-swf |
651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
689 | 0 | 0 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |D s |
689 | 0 | 1 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 0 | |5 DE-604 | |
856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018982941&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018982941&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Klappentext |
999 | |a oai:aleph.bib-bvb.de:BVB01-018982941 |
Datensatz im Suchindex
_version_ | 1804141155911204864 |
---|---|
adam_text | Contents
Preface
xiii
Acknowledgments
xv
About the author
xvii
Introduction
xix
1
History of health care financing in the USA
1
Introduction
1
The 19th century
2
The Progressive Era
3
The
1920s 4
The
1930s 5
The
1940s 8
The
1950s 9
The
1960s 11
The
1970s 12
The
1980s 17
The
1990s 19
The
21st
century
21
The year
2012 23
2
The costs of American health care
27
Introduction
27
Some economic definitions
28
What US health care spending has not solved
30
Background of rising costs
38
Societal impact of health care costs
40
Why health care costs outpace general economy
45
Addressing rising costs
46
viii
I Contents
The high costs of health care: the reasons why
49
Introduction
49
Evolution of health care services
50
Origins and elements in health care crisis
52
Health care costs
53
Nation s health bill
54
Hospital costs
55
Physician services
57
The elderly
58
Health insurance
60
Medicaid and Medicare
63
Manpower
66
Resolving the health care crisis
70
The future
73
Physician care
77
Introduction
77
Manpower
78
Physician reimbursement
83
Medical malpractice
89
Practice patterns
92
Conclusion
94
Prescription drugs
99
Introduction
99
Background of prescription drug costs
101
Brand name versus generic drugs: differences and costs
103
FDA s assurance of quality drugs
105
Pharmacists
106
Ways to pay for prescription drugs
108
Conclusion
116
Hospital care
119
Introduction
119
Character of hospitals
121
Hospital costs
121
Hospital utilization: a brief profile
127
Diagnosis-related groups
128
Unbundling the diagnostic codes
131
Hospital medications
133
Report cards
137
Conclusion
138
Contents
І
ix
7
Medical technology
143
Introduction
143
History of medical technology assessment
143
The cost drivers
147
Financial impact of new medical technology
149
Factors influencing growth of new technology
151
Medical technology expenditures
152
Unhealthy dilemmas
153
The British view
153
The future
154
8
Nursing home care
159
Introduction
159
Services available in nursing homes
162
Classification of nursing homes
162
Definition of a skilled nursing home
164
Components of nursing home care
168
Medicare s Nursing Home Compare
173
Financing nursing home care
174
The USA and the UK
179
9
Home care and hospice care
183
Introduction
183
Basic services
184
Financial advantages of home care
186
Availability of home care
186
Definition of bonded, licensed, and certified health personnel
186
How to find home care agency services
187
Medicare s Home Health Compare
190
Home care personnel
191
Cost of home care services
192
How to finance home health care services
192
Hospice care
198
Financing hospice care services
200
Finding hospice care
202
Conclusion
202
10
Health care planning
205
Introduction
205
Definition of health planning
207
The historical development of planning
209
Health Planning Act of
1974
212
[
Contents
Aftermath of the
1974
Planning Law Certificate
of Need laws
214
Proponents of CON programs
217
Critics of CON programs
219
The future
220
1
1
Private health insurance
225
Introduction
225
History of private health insurance
230
Federal laws and programs
233
Private health insurance industry
238
Shortcoming of insurance
239
Costs and inadequacy of insurance protection
241
Impact of health costs on US business
242
Private business cost initiatives
245
Conclusion
246
12
Managed care
251
Introduction
251
What is managed care?
252
Health maintenance organizations
253
Definition of prepaid group practice
254
Evolution of HMOs
256
Health Maintenance Organization Act of
1973
259
Other forms of managed care
262
Prescription drug coverage
264
Impact on the pharmaceutical industry
265
Conclusion
271
13
Medicaid and Medicare
273
introduction
273
Medicaid
275
Medicare
276
Conclusion
294
14
Health care fraud and abuse
299
Introduction
299
Definition
300
Nature of fraud
300
US initiatives against fraud and abuse
303
Health Insurance Portability and Accountability Act
of
1996
(PL
104-191) 304
Contents
I
xi
Civil Monetary Penalties Law
305
Balanced Budget Act of
1997
(PL
105-34,
Tax)
(PL
105-33,
Spending)
308
Operation Restore Trust
309
Necessity of US fraud initiatives
313
Medicare fiscal intermediaries and carriers
314
Coding issues
316
Managed care
317
Impact of drug industry activities on public
programs
-
view of DHHS
318
The future
324
15
National health insurance
327
Introduction
327
From ancient Greece
327
Burdens and stresses
329
Coalescing offerees for national health insurance
332
What s past is prologue
335
Socialized medicine
336
American proposals
339
Conclusion
342
Index
349
Health
Economies
Jordan Braverman
Health Economics is an introductory discourse of health care in America
today designed to acquaint students with a practical analysis of the
prominent economic issues. It considers health care in terms of cost,
affordability and historical development and assesses contributing
factors to the economic health crisis, including medical technology,
prescription drugs and hospital care. Addressing the magnitude of
the economic crisis, as well as physician and nursing home care and
managed care, coverage also includes:
home and hospice care
health care planning
private health insurance
Medicaid and Medicare
health care fraud and abuse
national health insurance.
The economics of each field are discussed in detail, with all their socio-
economic and political ramifications both within and outside the
health care system. This insightful and timely book will be an invaluable
resource for students of any health care discipline, practicing health
care physicians, economists, sociologists and health care researchers
wishing to know more about the current health care crisis in the USA
and what mechanisms exist to counter it.
Jordan Braverman is an author who served as Director of Health Policy
Analysis at Georgetown University Health Policy Center and also Director of
Health Policy at the American Pharmaceutical Association, Pharmaceutical
Manufacturers Association and Blue Cross Association.
|
any_adam_object | 1 |
author | Braverman, Jordan |
author_facet | Braverman, Jordan |
author_role | aut |
author_sort | Braverman, Jordan |
author_variant | j b jb |
building | Verbundindex |
bvnumber | BV036092362 |
callnumber-first | R - Medicine |
callnumber-label | RA410 |
callnumber-raw | RA410.53 |
callnumber-search | RA410.53 |
callnumber-sort | RA 3410.53 |
callnumber-subject | RA - Public Medicine |
classification_rvk | QX 700 XE 1600 |
classification_tum | MED 722f |
ctrlnum | (OCoLC)624428773 (DE-599)BVBBV036092362 |
dewey-full | 338.4336210973 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 338 - Production |
dewey-raw | 338.4336210973 |
dewey-search | 338.4336210973 |
dewey-sort | 3338.4336210973 |
dewey-tens | 330 - Economics |
discipline | Wirtschaftswissenschaften Medizin |
edition | 1. ed. |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02006nam a2200481 c 4500</leader><controlfield tag="001">BV036092362</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130108 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">100323s2010 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780853698678</subfield><subfield code="9">978-0-85369-867-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0853698678</subfield><subfield code="9">0-85369-867-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)624428773</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV036092362</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1050</subfield><subfield code="a">DE-11</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA410.53</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4336210973</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QX 700</subfield><subfield code="0">(DE-625)142186:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XE 1600</subfield><subfield code="0">(DE-625)152626:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 722f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Braverman, Jordan</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Health economics</subfield><subfield code="c">Jordan Braverman</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London [u.a.]</subfield><subfield code="b">Pharmaceutical Press</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XX, 359 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmacy business administration series</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Assurance-maladie - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Soins intégrés de santé - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Soins médicaux - Coût - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Économie de la santé - États-Unis</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018982941&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018982941&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Klappentext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-018982941</subfield></datafield></record></collection> |
geographic | USA (DE-588)4078704-7 gnd |
geographic_facet | USA |
id | DE-604.BV036092362 |
illustrated | Illustrated |
indexdate | 2024-07-09T22:11:23Z |
institution | BVB |
isbn | 9780853698678 0853698678 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-018982941 |
oclc_num | 624428773 |
open_access_boolean | |
owner | DE-1050 DE-11 DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
owner_facet | DE-1050 DE-11 DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
physical | XX, 359 S. graph. Darst. |
publishDate | 2010 |
publishDateSearch | 2010 |
publishDateSort | 2010 |
publisher | Pharmaceutical Press |
record_format | marc |
series2 | Pharmacy business administration series |
spelling | Braverman, Jordan Verfasser aut Health economics Jordan Braverman 1. ed. London [u.a.] Pharmaceutical Press 2010 XX, 359 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Pharmacy business administration series Assurance-maladie - États-Unis Soins intégrés de santé - États-Unis Soins médicaux - Coût - États-Unis Économie de la santé - États-Unis Gesundheitsökonomie (DE-588)4130935-2 gnd rswk-swf USA (DE-588)4078704-7 gnd rswk-swf Gesundheitsökonomie (DE-588)4130935-2 s USA (DE-588)4078704-7 g DE-604 Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018982941&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018982941&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Klappentext |
spellingShingle | Braverman, Jordan Health economics Assurance-maladie - États-Unis Soins intégrés de santé - États-Unis Soins médicaux - Coût - États-Unis Économie de la santé - États-Unis Gesundheitsökonomie (DE-588)4130935-2 gnd |
subject_GND | (DE-588)4130935-2 (DE-588)4078704-7 |
title | Health economics |
title_auth | Health economics |
title_exact_search | Health economics |
title_full | Health economics Jordan Braverman |
title_fullStr | Health economics Jordan Braverman |
title_full_unstemmed | Health economics Jordan Braverman |
title_short | Health economics |
title_sort | health economics |
topic | Assurance-maladie - États-Unis Soins intégrés de santé - États-Unis Soins médicaux - Coût - États-Unis Économie de la santé - États-Unis Gesundheitsökonomie (DE-588)4130935-2 gnd |
topic_facet | Assurance-maladie - États-Unis Soins intégrés de santé - États-Unis Soins médicaux - Coût - États-Unis Économie de la santé - États-Unis Gesundheitsökonomie USA |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018982941&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018982941&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT bravermanjordan healtheconomics |